Ligand validation:5OM7

DM2: DOXORUBICIN

DM2 is a Ligand Of Interest in 5OM7 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5OM7_DM2_A_501	74%	49%	0.1	0.928	0.99	0.98	2	3	1	0	100%	1
6FTP_DM2_B_501	11%	57%	0.238	0.758	0.76	0.89	-	2	2	0	100%	0.8
1DA9_DM2_A_7	84%	25%	0.092	0.952	1.29	1.76	7	13	0	0	100%	1
8R2J_DM2_B_302	60%	65%	0.151	0.937	0.56	0.78	-	1	11	0	100%	1
4ZVM_DM2_A_303	46%	57%	0.152	0.888	0.76	0.9	-	2	0	0	100%	1
4DX7_DM2_A_1105	26%	14%	0.185	0.825	2.52	1.39	12	7	27	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.